Pharmacy
Sandoz announces deal to commercialise biosimilar ustekinumab in Europe and North America
September 11, 2023Research and Development Pharmacy, SB17, Sandoz, commercialisation, ustekinumab
Sandoz has announced that it has entered into a development and commercialisation agreement with Samsung Bioepis, providing Sandoz the exclusive …
CymaBay shares results from phase 3 RESPONSE trial for seladelpar
September 8, 2023Research and Development CymaBay, PBC, Pharmacy, clinical trial, seladelpar
CymaBay Therapeutics has announced positive topline results from its phase 3 RESPONSE study which assessed the safety and efficacy of …
FDA approves new ADHD and BED generics
September 1, 2023Medical Communications BED, FDA, Pharmacy, generic medicines
The US Food and Drug Administration (FDA) has announced that it has approved several first generics of Takeda’s Vyvanse (lisdexamfetamine …
Astellas set to open new life sciences facilities in Cambridge, Massachusetts
August 10, 2023Business Development Astellas Pharma, Pharmacy, pharmaceutical, science facility
On 9 August 2023, Astellas Pharma announced its plans to open what it has described as a “state-of-the-art life sciences …
EureKING planning creation of new biotech company through the acquisition of SCTbio
August 9, 2023Business Services, Research and Development Pharmacy
On 9 August 2023, eureKING announced it is set to acquire the pharmaceutical company SCTbio which specializes in cell and …
Biopharmaceutical company EQRx set to be acquired by Revolution Medicines
August 2, 2023Research and Development EQRx, Pharmacy, biopharmaceutical, pharmaceutical, revolution medicines
On 1 August 2023, Revolution Medicines signed an official agreement confirming the acquisition of the biopharmaceutical company EQRx. The deal …
Biovian announces investment in manufacturing facility in Finland
July 26, 2023Manufacturing and Production Biovian, Pharmacy, facility, manufacturing
Biopharmaceutical based contract development and manufacturing organisation (CDMO) Biovian OY has announced an investment of over €50m to expand its …
WHO releases Medical Product Alert for contaminated cough syrup
July 20, 2023Medical Communications Pharmacy, WHO, cough syrups, medical product alert, world health organization
The World Health Organization (WHO) has shared a Medical Product Alert for an additional contaminated cough syrup medicine identified in …
Inizio Engage launches Patient Access Services – an integrated suite of patient support services to enhance access and adherence for specialty therapies
July 18, 2023Business Services Inizio Engage, Patient Access Services, Pharmacy, patient support
Fort Washington, US — Inizio Engage is pleased to announce the launch of Patient Access Services. This custom-built, integrated suite of patient support services …
Recursion and NVIDIA partner for AI-enabled drug discovery developments
July 13, 2023Research and Development AI, Pharmacy, Recursion, drug discovery
Clinical stage biotech company Recursion has announced a $50m investment by NVIDIA, intended to accelerate the development of its AI …
Virtual Inspections: Embracing the Digital Change
July 12, 2023Manufacturing and Production ACG, Pharmacy, digital, manufacturing, virtual inspections
Virtual inspections must become a part of companies’ repertoires if they aim to maintain quality standards in their organisations. Digital …
Croda International acquires Solus Biotech
July 4, 2023Business Services Croda International, Pharmacy, Solus Biotech, acquisition
Croda International has confirmed that it has successfully acquired Solus Biotech, following receipt of approval from the South Korean regulatory …
Anavex Life Sciences and Partex NV Group announce AI-based strategic partnership to enhance patient experience
June 28, 2023Research and Development AI, Anavex Life Sciences, Partex NV Group, Pharmacy, patient experience
US-based clinical-stage biopharmaceutical company Anavex Life Sciences and German digital pharma platform Partex NV Group have announced a strategic partnership …
Astellas Pharma shares positive results from phase 3b trial of Fezolinetant for menopause symptoms
June 28, 2023Medical Communications Astellas Pharma, Pharmacy, clinical trial, fezolinetant, menopause
Astellas Pharma has announced positive topline results from the phase 3b DAYLIGHT clinical trial for fezolinetant, its investigational oral, nonhormonal …
FDA approves Pfizer’s Litfulo for patients with severe alopecia areata
June 26, 2023Medical Communications FDA, Litfulo, Pfizer, Pharmacy, alopecia, alopecia areata
Pfizer has announced that the US Food and Drug Administration (FDA) has approved its Litfulo (ritlecitinib) for patients over the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
